Shilpa Medicare's Stock Sees 6.12% Increase, Outperforms Market with 'Hold' Rating
Shilpa Medicare, a midcap pharmaceutical company, has seen a 6.12% increase in its stock price on November 21, 2024. This rise in stock value has been attributed to the company's strong performance in the market.
According to MarketsMOJO, a leading financial analysis platform, Shilpa Medicare's stock has been given a 'Hold' rating. This indicates that the stock is expected to perform steadily in the near future.
The company's stock is currently trading at a price that is 2.07% away from its 52-week high of Rs 959.95. This shows that the stock is performing well and is close to reaching its highest value in the past year.
In today's trading session, Shilpa Medicare has outperformed the pharmaceutical and drugs sector by 7.3%. This is a positive sign for the company and shows its strong position in the market.
The stock has been on a consecutive gain for the last 2 days and has seen a 9.23% increase in its value during this period. It also opened with a gain of 2.34% today, indicating a positive trend for the company.
Shilpa Medicare's stock touched an intraday high of Rs 940.5, which is a 6.89% increase from its previous closing price. This shows a strong demand for the company's stock in the market.
The company's stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the stock and shows that it is performing well in the market.
In comparison to the overall market performance, Shilpa Medicare's stock has outperformed the Sensex by 6.52% in the last 1 day and by 13.34% in the last 1 month. This shows that the company's stock is performing better than the market average, making it a good investment option for investors.
Overall, Shilpa Medicare's stock has shown a strong performance in the market, with a steady increase in its value. With a 'Hold' rating from MarketsMOJO and positive trends in its stock price, the company is expected to continue its growth in the pharmaceutical and drugs industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
{{text.big_txt}}
{{text .small_txt}}
{{dashverdictresult.dashboard.stock_details.short_name}}
SEND BY EMAIL
Register now to see if the stock’s characteristics match your investment style
Subscribe now to see if the stock's characteristics match your investment style
{{dashverdictresult.dashboard.risk_return_voltality.risk_type}}, {{dashverdictresult.dashboard.risk_return_voltality.return_type}}
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
Create your portfolio and know how much should this stock be in your portfolio
Subscribe now to know how much you should hold in this stock
We have found 2 better stocks that you can consider
{{dashverdictresult.dashboard.return_text}}
Investors Returns (3 years) –
| Period | 6M | 1Y | 2Y | 3Y |
| {{ keyd.val }} | ||||
| {{ keyd.val }} |
Quality: {{dashverdictresult.dashboard.dotsummary.q_txt}}
Valuation: {{dashverdictresult.dashboard.dotsummary.v_txt}}
Quarterly Financial Trend: {{dashverdictresult.dashboard.dotsummary.f_txt}}
Technicals: {{dashverdictresult.dashboard.dotsummary.tech_txt}}
Stock Info:
BSE – {{dashverdictresult.dashboard.stock_details.scripcode}}/ NSE – {{dashverdictresult.dashboard.stock_details.symbol}}
Market Cap – {{dashverdictresult.dashboard.priceinfo.mcap_class}} (Rs. {{dashverdictresult.dashboard.priceinfo.mcap| number :0}} cr)
Sector – {{dashverdictresult.dashboard.stock_details.ind_name}}
52 w H/L (Rs.) – {{dashverdictresult.dashboard.priceinfo.wk_high52}}/{{dashverdictresult.dashboard.priceinfo.wk_low52}}
Average vol (6M) – {{dashverdictresult.dashboard.priceinfo.vol}}
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
